Cancer-associated mutations in IDH1 and IDH2 detected in a wide range of human cancers [90] can result in neomorphic enzymes producing 2-HG, instead of α-KG, resulting in global epigenetic changes due to inhibition of JMJDs as well as TET enzymes [90]. The gene discussed is IDH1; the disease is cancer.